Open AccessImmunogenicity and Safety of Trivalent Split Influenza Vaccine in Healthy Korean Adults with Low Pre-Existing Antibody Levels: An Open Phase I Trial
Author(s) -
Kyuri Kang,
Seunghoon Han,
Tae Kyung Hong,
Sangil Jeon,
Jeongki Paek,
Jin Han Kang,
DongSeok Yim
Publication year - 2016
Publication title -
yonsei medical journal/yonsei medical journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.702
H-Index - 63
eISSN - 1976-2437
pISSN - 0513-5796
DOI - 10.3349/ymj.2016.57.6.1354
Subject(s) - medicine , seroconversion , adverse effect , immunogenicity , confidence interval , influenza vaccine , clinical trial , trivalent influenza vaccine , titer , hemagglutination assay , antibody , immunology , vaccination
A phase I clinical trial was conducted to evaluate the immunogenicity and safety of newly developed egg-cultivated trivalent inactivated split influenza vaccine (TIV) in Korea.